FR2292M - Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine. - Google Patents

Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.

Info

Publication number
FR2292M
FR2292M FR902199A FR902199A FR2292M FR 2292 M FR2292 M FR 2292M FR 902199 A FR902199 A FR 902199A FR 902199 A FR902199 A FR 902199A FR 2292 M FR2292 M FR 2292M
Authority
FR
France
Prior art keywords
ergotamine
hydantoin
caffeine
dihydro
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR902199A
Other languages
English (en)
Inventor
Aurelio Cerletti
Albert Fanchamps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to FR902199A priority Critical patent/FR2292M/fr
Priority to GB24025/63A priority patent/GB1043842A/en
Priority to US290300A priority patent/US3160562A/en
Application granted granted Critical
Publication of FR2292M publication Critical patent/FR2292M/fr
Priority to OA51493A priority patent/OA01971A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR902199A 1962-06-27 1962-06-27 Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine. Expired FR2292M (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR902199A FR2292M (fr) 1962-06-27 1962-06-27 Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
GB24025/63A GB1043842A (en) 1962-06-27 1963-06-17 Pharmaceutical compositions for treating headache
US290300A US3160562A (en) 1962-06-27 1963-06-25 Composition containing ergotamine, caffeine and hydantoin derivatives for cephalalgia
OA51493A OA01971A (fr) 1962-06-27 1964-12-31 Combinaison nouvelle à base de dihydro-ergotamine de caféine et d'une hydantoine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR902199A FR2292M (fr) 1962-06-27 1962-06-27 Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.

Publications (1)

Publication Number Publication Date
FR2292M true FR2292M (fr) 1964-01-27

Family

ID=8781986

Family Applications (1)

Application Number Title Priority Date Filing Date
FR902199A Expired FR2292M (fr) 1962-06-27 1962-06-27 Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.

Country Status (4)

Country Link
US (1) US3160562A (fr)
FR (1) FR2292M (fr)
GB (1) GB1043842A (fr)
OA (1) OA01971A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165376A (en) * 1971-01-29 1979-08-21 Lake Shore Roentgenology, Ltd. Treatment of the acute after-effects resulting from alcohol ingestion
US4315937A (en) * 1979-11-28 1982-02-16 Sandoz Ltd. Ergots and their use in treating minimal brain dysfunction
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US5169849A (en) * 1982-02-01 1992-12-08 Sandoz Ltd. Nasal pharmaceutical compositions
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
GB1043842A (en) 1966-09-28
OA01971A (fr) 1970-05-05
US3160562A (en) 1964-12-08

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR1837M (fr) Médicament a base d'un dérivé méthylolé de la β-carboline.
FR2337M (fr) Médicament a base de dérivés d'hydrazine substitués.
FR1957M (fr) Extraits d'organes.
FR1038M (fr) Médicament a base d'aspirine.
FR2292M (fr) Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
FR3702M (fr) Médicament a base d'anguidine et de ses dérivés.
FR2186M (fr) Médicament a base d'un dérivé de l'aniline.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR2012M (fr) Médicament a base d'un nouvel heptapeptide.
FR1544M (fr) Médicament a base d'un dérivé de la glucosamine.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR2869M (fr) Médicament a base d'un dérivé de la cymarine.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2671M (fr) Médicament a base de dérivés d'hydrazine.
FR3323M (fr) Médicament a base de dérivé de l'aza-thiaxanthene.
FR2220M (fr) Médicament sédatif a base de dérivé de carbamate d'aryloxy-alcoyle.
FR2415M (fr) Médicament a base d'éthanolamines substituées.
FR1826M (fr) Médicament a base d'un dérivé de la guanidine.
FR2359M (fr) Médicament antiphlogistique a base d'hécogénine.
FR2093M (fr) Médicament a base de dérivé d'hydroxy-dibenzocycloheptane.
FR3565M (fr) Médicament a base d'un nonapeptide-amide cyclique.
FR2877M (fr) Médicament a base d'amides.
FR2034M (fr) Médicament a base d'une combinaison d'ocytocine et d'ergométrine ou de méthyl-ergométrine.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.